Cardiology

Top Story

Joint guideline offers new algorithm for treatment of pulmonary hypertension

August 29, 2015

LONDON — In a new guideline, the European Society of Cardiology and the European Respiratory Society outline a treatment algorithm for pulmonary hypertension and offer advice on when to use newly approved drugs.

Since the release of previous guidelines in 2009, “a huge amount of evidence has accumulated on the pharmacological treatment of patients with PAH [pulmonary arterial hypertension]. We have reconciled all the available data in a comprehensive treatment algorithm and in multiple tables that give recommendations for different patient risk profiles,” Nazzareno Galiè, MD, associate professor of cardiology at the University of Bologna, Italy, and chairperson of the task force that wrote the document, said in a press release. “The information is inclusive enough to be applicable in different health care systems with heterogeneous drug availability. The algorithm for [chronic thromboembolic pulmonary hypertension] is more detailed and recommends specific imaging tests to better define the treatment strategy."

Meeting News Coverage

Meta-analysis: LAA occlusion linked with improved outcomes vs. warfarin, aspirin in patients with AF

August 29, 2015
LONDON — Left atrial appendage occlusion was associated with improved mortality and similar stroke outcomes compared with warfarin in patients with atrial…
Meeting News Coverage

New ESC guideline recommends radial approach for PCI in patients with ACS

August 29, 2015
LONDON — A new European Society of Cardiology guideline on management of ACS without persistent ST-segment elevation recommends that PCI performed on patients with…
In the Journals

Bivalirudin compares favorably to heparin, GPIs in patients with diabetes undergoing PCI

August 28, 2015
Treatment with bivalirudin yielded similar 30-day ischemic outcomes vs. heparin and glycoprotein inhibitors, with significantly lower rates of major and minor bleeding…
In the Journals

CV events decreased in US since 2005; decline more pronounced in certain populations

August 28, 2015
Although major CV events and all-cause mortality rates in the United States decreased significantly between 2005 and 2011 among adults with diabetes, history of CVD or…
More News Headlines »
CME
Cardiology Case Consults

The Patient With Idiopathic Pulmonary Fibrosis

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with idiopathic pulmonary fibrosis.
More »
Video
VIDEO: Prenatal intervention may improve neurodevelopmental outcomes from congenital heart defects

VIDEO: Prenatal intervention may improve neurodevelopmental outcomes from congenital heart defects

July 23, 2015
PHILADELPHIA — In this video, J. William Gaynor, MD, a cardiac surgeon at the Children's Hospital of…
More »
CME
Highlights from Lipid Forum 2015™: Focus on Hypertriglyceridemia

Highlights from Lipid Forum 2015®: Focus on Hypertriglyceridemia

This activity is supported by an educational grant from AstraZeneca.

Hypertriglyceridemia is a highly prevalent yet modifiable risk factor for atherosclerotic disease, pancreatitis, and…
More »
morganatic-roan
morganatic-roan